Relationship between metabolic syndrome and meal‐induced glucagon like peptide‐1 response in type 1 diabetic patients在1型糖尿病患者中代谢综合征与进餐诱导的胰高血糖素样肽‐1应答之间的关系

Publisher： John Wiley & Sons Inc

E-ISSN： 1753-0407|7|3|340-346

ISSN： 1753-0393

Source： JOURNAL OF DIABETES, Vol.7, Iss.3, 2015-05, pp. : 340-346

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Early use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in Type 2 diabetes

By Ross Stuart A.   Ballantine Jane  

Current Medical Research and Opinion, Vol. 29, Iss. 12, 2013-12 ,pp. : 1617-1626

Informa Healthcare

Access to resources Recommend Favorite

Role of glucagon-like peptide-1 in the pathogenesis of experimental irritable bowel syndrome rat models

By          

International Journal of Molecular Medicine, Vol. 31, Iss. 3, 2013-01 ,pp. : 607-613

Spandidos Publications

Access to resources Recommend Favorite

Glucagon‐like peptide 1 receptor agonists and cardiovascular risk in type 2 diabetes: a clinical perspective

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 4, 2015-04 ,pp. : 335-342

John Wiley & Sons Inc

Access to resources Recommend Favorite

Overnight hypoxic exposure and glucagon-like peptide-1 and leptin levels in humans

By Snyder Eric M.   Carr Richard D.   Deacon Carolyn F.   Johnson Bruce D.  

Applied Physiology, Nutrition, and Metabolism, Vol. 33, Iss. 5, 2008-10 ,pp. : 929-935

NRC Research Press

Access to resources Recommend Favorite

Effects of gastric inhibitory polypeptide, glucagon‐like peptide‐1 and glucagon‐like peptide‐1 receptor agonists on Bone Cell Metabolism

By  

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 122, Iss. 1, 2018-01 ,pp. : 25-37

John Wiley & Sons Inc

Access to resources Recommend Favorite